https://www.selleckchem.com/products/amg-900.html
03 at 30 days). Lower average surgical risk scores were associated with lower rates of fatal or disabling stroke (p=0.02 at 30 days). We found that treatment of aortic stenosis with TAVI compared with SAVR was not associated with an overall reduced risk in fatal or disabling stroke. Subgroup analyses suggested a lower risk of fatal or disabling stroke with TAVI in situations which reflect contemporary practice. We found that treatment of aortic stenosis with TAVI compared with SAVR was not associated with an overall reduced risk in fata
Like
Comment
Share
